Mechanisms of resistance to structurally diverse antiestrogens differ under premenopausal and postmenopausal conditions: evidence from in vitro breast cancer cell models.
about
Therapeutically activating RB: reestablishing cell cycle control in endocrine therapy-resistant breast cancer.Estrogen receptor alpha 46 is reduced in tamoxifen resistant breast cancer cells and re-expression inhibits cell proliferation and estrogen receptor alpha 66-regulated target gene transcription.Progesterone receptor action: defining a role in breast cancerEGFR signaling in breast cancer: bad to the bone.Effects of Combination of Estradiol with Selective Progesterone Receptor Modulators (SPRMs) on Human Breast Cancer Cells In Vitro and In Vivo.Proteomic analysis of acquired tamoxifen resistance in MCF-7 cells reveals expression signatures associated with enhanced migration.Analysis of factors affecting endocrine therapy resistance in breast cancer.c-Src modulates estrogen-induced stress and apoptosis in estrogen-deprived breast cancer cells.Loss of pigment epithelium-derived factor: a novel mechanism for the development of endocrine resistance in breast cancer.Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer.GPR30 as an initiator of tamoxifen resistance in hormone-dependent breast cancer.GPER functions as a tumor suppressor in triple-negative breast cancer cells.Nitric oxide is cytoprotective to breast cancer spheroids vulnerable to estrogen-induced apoptosis.Antrodia cinnamomea extract inhibits the proliferation of tamoxifen-resistant breast cancer cells through apoptosis and skp2/microRNAs pathway.
P2860
Q30419997-BC309883-9222-4898-920E-0D2827CCC345Q33872793-BA3EA97C-15DC-406A-ABAA-65DFEB377964Q33998721-E275F3F3-5EB8-4CB5-9B2C-D5A8D98C950EQ34348232-AAC148D4-19BE-409F-B88D-B809BBEE4810Q35969254-F96C7CFD-7E4D-4D30-B4C2-9D7F1349E845Q36245528-97D40906-DD1B-4EB0-9C58-78867A462EC9Q36502389-F3CE64D8-863F-418C-81D9-689C87844ACFQ37025060-E0106D86-DFEF-4D38-A26F-98953DDC2785Q37531200-B895EC4E-6E82-47CB-A995-8CDB81D4D6A0Q37533025-4568CC07-D425-4487-80A8-8BBA441F1B7AQ37689922-B6E1F3EC-2822-4194-A46F-2BA7F33D8FCFQ39022382-25D28BA3-8DBC-4C41-B87E-A71A29DAE982Q49348415-8C95A5D3-66E7-4055-BCAA-A0E5D3CC749BQ53685283-3E6AFC86-9426-4FE4-BC33-2D8693206248
P2860
Mechanisms of resistance to structurally diverse antiestrogens differ under premenopausal and postmenopausal conditions: evidence from in vitro breast cancer cell models.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Mechanisms of resistance to st ...... tro breast cancer cell models.
@ast
Mechanisms of resistance to st ...... tro breast cancer cell models.
@en
type
label
Mechanisms of resistance to st ...... tro breast cancer cell models.
@ast
Mechanisms of resistance to st ...... tro breast cancer cell models.
@en
prefLabel
Mechanisms of resistance to st ...... tro breast cancer cell models.
@ast
Mechanisms of resistance to st ...... tro breast cancer cell models.
@en
P2093
P2860
P356
P1433
P1476
Mechanisms of resistance to st ...... tro breast cancer cell models.
@en
P2093
Ji-Ping Wang
Richard J Santen
Sarah Aiyar
Tae-Hyun Kim
P2860
P304
P356
10.1210/EN.2008-1195
P407
P577
2009-01-29T00:00:00Z